No abstract available
MeSH terms
-
Administration, Oral
-
Anticoagulants / administration & dosage
-
Anticoagulants / therapeutic use*
-
Clinical Trials, Phase II as Topic
-
Factor Xa Inhibitors
-
Humans
-
Morpholines / therapeutic use
-
Rivaroxaban
-
Thiophenes / therapeutic use
-
Thrombosis / drug therapy*
-
Vitamin K / antagonists & inhibitors
-
Warfarin / adverse effects*
Substances
-
Anticoagulants
-
Factor Xa Inhibitors
-
Morpholines
-
Thiophenes
-
Vitamin K
-
Warfarin
-
Rivaroxaban